Ferrostatin-1 Prevents Salivary Gland Dysfunction in an Ovariectomized Rat Model by Suppressing Mitophagy-Driven Ferroptosis
Authors:
- Gi-Cheol ParkGPGi-Cheol Park
- Soo-Young BangSBSoo-Young Bang
- Ji Min KimJKJi Min Kim
- Sung-Chan ShinSSSung-Chan Shin
- Yong-Il CheonYCYong-Il Cheon
- Hanaro ParkHPHanaro Park
- Sunghwan SuhSSSunghwan Suh
- Jung Hwan ChoJCJung Hwan Cho
- Eui-Suk SungESEui-Suk Sung
- Minhyung LeeMLMinhyung Lee
- Jin-Choon LeeJLJin-Choon Lee
- Byung-Joo LeeBLByung-Joo Lee
Preprint
- 26 June 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Salivary gland dysfunction is a common but underexplored complication of menopause that contributes to oral dryness, dysphagia, and increased risk of infection. Although ferroptosis, a form of regulated necrotic cell death driven by iron-dependent lipid peroxidation, has recently been implicated in postmenopausal tissue degeneration, its regulatory mechanisms in salivary glands remain unclear. In this study, we investigated the roles of mitochondrial dysfunction and mitophagy in driving ferroptosis-induced salivary gland injury in an ovariectomized (OVX) rat model of estrogen deficiency. OVX rats exhibited elevated markers of oxidative stress, lipid accumulation, and iron overload, and suppressed GPX4 activity in the salivary glands, consistent with ferroptotic activation. These changes were accompanied by impaired mitochondrial dynamics (MFN1 and OPA1), decreased expression of mitochondrial antioxidant regulators (PGC-1α, SOD, and catalase), and upregulation of mitophagy-related genes (PINK1, ULK1, Rab9, and LC3B), as well as LAMP, a lysosomal marker involved in autophagosome-lysosome fusion, while ferritinophagy (NCOA4) remained unchanged. Early administration of ferrostatin-1 effectively suppressed these pathological changes, preserving both glandular structure and function, as evidenced by the restored AQP5 and AMY2A expression. Collectively, our findings reveal that ferroptosis in estrogen-deficient salivary glands is regulated by mitochondrial instability and aberrant mitophagy, and ferrostatin-1 mitigates this cascade through multi-level mitochondrial protection. These results highlight ferrostatin-1 as a promising preventive agent against menopause-associated salivary gland dysfunction, with broader implications for organ-specific ferroptosis modulation.Keywords
All Related Versions
- Version 1, 2025-06-26, Preprints
- Published version: Antioxidants, 14 (9), 1058.
This publication has 36 references indexed in Scilit:
- TGFβ2‐Driven Ferritin Degradation and Subsequent Ferroptosis Underlie Salivary Gland Dysfunction in Postmenopausal ConditionsAdvanced Science, 2024
- Beyond ferrostatin-1: a comprehensive review of ferroptosis inhibitorsTrends in Pharmacological Sciences, 2023
- Ferrostatin-1 improves BMSC survival by inhibiting ferroptosisArchives of Biochemistry and Biophysics, 2023
- Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applicationsCell, 2022
- Insight into the mechanism of ferroptosis inhibition by ferrostatin-1Redox Biology, 2020
- Role of Mitochondria in FerroptosisMolecular Cell, 2019
- Ferroptosis: process and functionCell Death & Differentiation, 2016
- Glutaminolysis and Transferrin Regulate FerroptosisMolecular Cell, 2015
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Depressive disorders and the menopause transitionMaturitas, 2012